Laurent M. Humeau
2022
In 2022, Laurent M. Humeau earned a total compensation of $1.6M as Chief Scientific Officer at Inovio Pharmaceuticals, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $152,275 |
|---|---|
| Option Awards | $449,936 |
| Salary | $508,314 |
| Stock Awards | $446,936 |
| Other | $13,000 |
| Total | $1,570,461 |
Humeau received $508.3K in salary, accounting for 32% of the total pay in 2022.
Humeau also received $152.3K in non-equity incentive plan, $449.9K in option awards, $446.9K in stock awards and $13K in other compensation.
Rankings
In 2022, Laurent M. Humeau's compensation ranked 2,145th out of 5,736 executives tracked by ExecPay. In other words, Humeau earned more than 62.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,145 out of 5,736 | 63rd |
Division Manufacturing | 1,155 out of 3,125 | 63rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 136 out of 485 | 72nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 89 out of 347 | 74th |
Industry Surgical and Medical Instruments and Apparatus | 75 out of 253 | 70th |
Source: SEC filing on March 28, 2023.
Humeau's colleagues
We found three more compensation records of executives who worked with Laurent M. Humeau at Inovio Pharmaceuticals in 2022.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021